EF
CRMD icon

Empowered Funds’s CorMedix CRMD Stock Holding History

Empowered Funds’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91M Sell
243,232
-23,405
-9% -$185K 0.01% 1215
2026
Q1 		$1.81M Buy
266,637
+134,733
+102% +$996K 0.01% 1156
2025
Q4 		$1.53M Buy
+131,904
New +$1.46M 0.03% 560

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Empowered Funds's CRMD Position: Q2 2026 in Review

Empowered Funds reduced its CorMedix (CRMD) stake by 8.8% in Q2 2026, selling an estimated $185K and leaving 243,232 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #1215.

Empowered Funds first reported a position in CRMD in Q4 2025 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Empowered Funds held 243,232 shares of CorMedix worth $1.91M as of Q2 2026.
  • Empowered Funds sold 23,405 CorMedix shares in Q2 2026, an estimated $185K.
  • CorMedix made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1215 holding.
  • Empowered Funds first reported a position in CorMedix in Q4 2025 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.